Last reviewed · How we verify
IV morphine sulfate or Sponsor-approved equivalent — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
IV morphine sulfate or Sponsor-approved equivalent (IV morphine sulfate or Sponsor-approved equivalent) — Pacira Pharmaceuticals, Inc.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| IV morphine sulfate or Sponsor-approved equivalent TARGET | IV morphine sulfate or Sponsor-approved equivalent | Pacira Pharmaceuticals, Inc | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- IV morphine sulfate or Sponsor-approved equivalent CI watch — RSS
- IV morphine sulfate or Sponsor-approved equivalent CI watch — Atom
- IV morphine sulfate or Sponsor-approved equivalent CI watch — JSON
- IV morphine sulfate or Sponsor-approved equivalent alone — RSS
Cite this brief
Drug Landscape (2026). IV morphine sulfate or Sponsor-approved equivalent — Competitive Intelligence Brief. https://druglandscape.com/ci/iv-morphine-sulfate-or-sponsor-approved-equivalent. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab